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CIntroduction: Recently, results from the large, randomized study to
rospectively evaluate reamed intramedullary nails in patients with
ibial fractures (SPRINT) trial suggested a benefit for reamed intramed-
llary nail insertion in patients with closed tibial shaft fractures largely
ased on cost-neutral autodynamizations and a potential advantage
or unreamed intramedullary nailing in open fractures. We performed
n economic evaluation to compare resource use and effectiveness of
eamed and unreamed intramedullary nailing using a cost-utility
nalysis. Methods: We calculated quality-adjusted life years (QALYs)
or each patient from a self-administered health utility index 3 ques-
ionnaire for the first 12months following the intramedullary nailing. A
onvenience sample of 235 SPRINT patients provided data on costs
ssociated with health care resource utilization. All costs are reported
n Canadian dollars for the 2008 financial year. Results: We found in-
remental effects of0.017 (95% confidence interval [CI]0.021–0.058) O
er, 29
al So
doi:10.1016/j.jval.2010.10.034nd 0.002 (95% CI 0.060–0.062) QALYs for patients treated with
eamed compared with unreamed intramedullary nails in closed and
pen fractures, respectively. The incremental costs for reamed com-
ared with unreamed intramedullary nailing were $51 Canadian dol-
ars (95% CI $2298–$2400) in closed tibial fractures and $2546 Cana-
ian dollars (95%CI $1773–$6864) in open tibial fractures. Unreamed
ailing dominated reamed nailing for both closed and open tibial frac-
ures; however, the cost and the utility results had high variability.
onclusion: Our economic analysis from a governmental perspective
uggests small differences in both cost and effectiveness with large
ncertainty between reamed and unreamed intramedullary nailing.
eywords: cost-utility analysis, economic analysis, reamed intramed-
llary nails, tibia fractures, unreamed intramedullary nails.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Tibial fractures are the most common long bone fractures and
constitute a major component of emergency operating room pro-
cedures in trauma centers. The National Center for Health Statis-
tics reports an annual incidence of 492,000 fractures of the tibia
and fibula per year in the United States [1]. Patients with tibial
fractures remain in the hospital for a total of 569,000 hospital days
and incur 825,000 physician visits per year, which imposes consid-
erable cost to the health care system [1]. Although evidence favors
the use of intramedullary nails to repair fractures of the tibia [2,3],
he choice between two alternative operative approaches, reamed
r unreamed intramedullary nailing, remains controversial [3–5].
A systematic search of the literature (MEDLINE, Cochrane Li-
rary, andHEED fromMarch 1988 toNovember 2009) revealed only
wo economic evaluations of reamed versus unreamed intramed-
* Address correspondence to:Mohit Bhandari, SPRINTMethods Cent
E-mail: bhandam@mcmaster.ca.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.ullary nailing [6,7]. The first analysis was a single center, observa-
tional study in 51 patients with open tibia fractures [6]. Conducted
from the hospital perspective, it found a trend toward lower costs
due to fewer secondary procedures with reamed intramedullary
nailing while healing rates remained similar for the two ap-
proaches [6]. The second was a model-based analysis using data
from small randomized clinical trials with methodological limita-
tions; it explored the cost associated with the treatment of low-
energy tibial shaft fractures and found that there were higher
costs associated with treatment with unreamed intramedullary
when compared to reamed intramedullary nailing [7].
Recently, results from the large, randomized study to prospec-
tively evaluate reamed intramedullary nails in patients with tibial
fractures (SPRINT) trial suggested a benefit for reamed intramed-
ullary nail insertion in patients with closed tibial shaft fractures,
largely due to fewer dynamizations, and a potential advantage for
3Wellington Street North, Suite 110, Hamilton, ON, Canada, L8L 8E7.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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451V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 4 5 0 – 4 5 7unreamed intramedullary nailing in open tibia fractures [8]. The
bjective of this economic evaluation was to compare resource
se and effectiveness of reamed and unreamed intramedullary
ailing in a cost-utility analysis. To meet this objective, we used
tilities, resource utilization from the index hospital stay, and
ata on re-operations collected prospectively as part of the SPRINT
rial. In addition, we collected data on other resources consumed
uring the 12 months’ follow-up retrospectively from a sample of
35 SPRINT patients.
Methods
The SPRINT trial
This economic analysiswas part of the SPRINT trialwith collection
of utilities and resource utilization data alongside the trial. The
design, baseline findings, and primary results of SPRINThave been
reported in detail [8,9]. Briefly, SPRINT (NCT00038129 at www
.Clinicaltrial.gov) was a multicenter, blinded randomized con-
trolled trial enrolling 1319 patients at 29 clinical sites in Canada,
the United States, and The Netherlands from July 2000 to Septem-
ber 2005. Patients were followed for 12 months post-surgery. Eli-
gible patients were skeletally mature and sustained a closed or
open shaft fracture (Tscherne Type 0-3, Gustilo Type I-IIIB) [10–12]
of the tibia amenable to operative fixation with an intramedullary
nail. Patients with pathologic fractures or likely problems with
maintaining follow-up were excluded. Since the main study re-
sults suggested different treatment effects for closed versus open
tibial fractures (interaction P 0.01), we included a stratified anal-
ysis by closed versus open fractures in this economic evaluation.
Perspective
This economic evaluation was performed from the viewpoint of
the Ontario Provincial Ministry of Health. All costs are expressed
in Canadian dollars for the 2008 financial year. While a compre-
hensive societal perspective is desirable, it was not feasible to re-
liably collect these data retrospectively (including out-of-pocket
expenses and lost productivity for patients, family members, and
other caregivers).
Utilities (quality-adjusted life years)
Utility is the preference or worth assigned to a particular health
status, on an interval scale ranging from 0 (death) to 1 (perfect
health) [13,14]. In order to estimate utility scores in SPRINT, par-
ticipants were asked to complete the self-administered health
utility index 3 (HUI3) questionnaire at 2 weeks after hospital dis-
charge, and at 3 months, 6 months, and 12 months post-surgery
[9]. We calculated quality-adjusted life years (QALYs) for each pa-
tient through conversion of corresponding HUI3 scores for the first
12 months following the intramedullary nailing.
Resource utilization and cost valuation
Data on resource utilization were collected from a convenience
sample of 235 patients from six study centers with a high recruit-
ment rate (three Canadian sites: St. Michael’s Hospital, Toronto,
ON; Hamilton Health Sciences – General Site, Hamilton, ON; and
LondonHealth Sciences, London, ON; and at three US sites: Boston
Medical Center, Boston, MA; Wake Medical Center, Winston-Sa-
lem, NC; and The University of Oklahoma Health Science Center,
OklahomaCity, OK). Data on the length of the index procedure, the
length of the index hospital stay, complications during index hos-
pitalization, and re-operations during the 12-month follow-up pe-
riod were collected prospectively alongside the trial. Data on re-
sources consumed during the 12-month follow-up period were
collected retrospectively through a medical record review. cIn an attempt to accurately reflect relative cost differences be-
tween groups, we focused on resource items that were potentially
consumed to a different degree by the two groups as a conse-
quence of the two different operative techniques. In other words,
we did not attempt to comprehensively estimate absolute costs of
intramedullary nailing procedures. Therefore, we considered only
re-operations that were classified by the outcome adjudication
committee as study events. Surgical procedures classified by the
adjudication committee as nonevents were re-operations deter-
mined by the circumstances of the injury rather than by the dif-
ferent operative techniques (e.g., planned re-operations, re-oper-
ations in patients with a fracture gap greater than 1 cm). Along the
same lines, we did not consider any after hours or weekend sur-
charges and consideredmaterial costs of intramedullary nails and
locking screws only for re-operations such as implant exchanges.
Based on the collected data on resource utilization fromall 6 cen-
ters we evaluated the costs as follows: Prices of operation and con-
sultation fees were determined from the Physician’s Schedule of
Benefits (February, 2008) [15].Weusedestimates fromtheEclipsysT2
Case Costing System in London ON (based on data from 2007), for
overhead costs of the operating room, fracture clinic, emergency
room, and for theward and rehabilitation institution costs. Prescrip-
tion medication prices were obtained from the Ontario Drug Benefit
Formulary [16]. Prices for drugs not listed on the formulary were ob-
tained from drug distributors. Mark-ups and dispensing fees were
added as appropriate. Formaterial costswe contactedmanufacturers.
Inpatient costs were derived from the following: 1) surgeon’s fee
depending on the type of operation; 2) the surgical assistant’s fee
depending on the type of operation; 3) the anesthetist’s fee; 4) the
fluoroscopy technician’s fee; 5) operating room overhead including
nursing staff, surgical supplies and infrastructure costs; 6) overhead
ward room costs; and 7) drugs related to the tibial fracture and ad-
ministered during hospital stay.
Outpatient costs included: 1) follow-up visits with the surgeon; 2)
surgical procedures performed during follow-up visits (e.g., cast ap-
plication, removal); 3) fracture clinic overhead; 4) outpatientdiagnos-
tic tests required (e.g., radiographs, ultrasound, bonedensity scan); 5)
rehabilitation institution services; 6) nonorthopedic outpatient ser-
vices (e.g., consultationwith aplastic surgeon, emergency roomcon-
sultation); and 7) drugs related to the tibial fracture and prescribed in
outpatient clinics. Resource utilization of physiotherapy, occupa-
tional therapy, social workers, and blood tests were not systemati-
cally captured and were therefore excluded from the analysis.
Statistical analysis
The cost-utility analysis consisted of first determining whether
one treatment dominated the other (i.e., lower costs and better
outcomes) and, failing that, determining the trade-off between
incremental costs and incremental effects calculated as the cost
per QALY gained as
[(mean annual cost per patient)R(mean annual cost per patient)UR] ⁄
[(mean QALY per patient)R(mean QALY per patient)UR]
here UR is the unreamed group and R is the reamed group. To
etermine the effect of uncertainty around QALY point estimates,
e conducted a bootstrapping analysis by performing a separate
ootstrap of 1000 replications for each of the two strata, open tibial
haft fractures and closed tibial shaft fractures. We plotted the
esults on the incremental cost-effectiveness plane and estimated
ncremental cost-effectiveness acceptability curves for both open
nd closed fractures, using the bootstrap data to determine the
robability that treatments are cost-effective according to various
ocietal willingness-to-pay thresholds for health improvements
i.e., willingness-to-pay per QALY gained). The bootstrapping pro-
edure was performed in S-PLUS version 8.0, (Insightful Corpora-
m
r
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sion 9.1 (SAS Institute, Cary, NC).
Because uncertainty concerning quality of life and resource
utilization is inherently part of the trial-based bootstrap analysis,
we conducted a series of one-way sensitivity analyses to investi-
gate the impact of varying unit costs by / 20%. In response to
reviewers’ comments, we additionally conducted a sensitivity
analysis excluding rehabilitation costs and a stratified analysis of
resource utilization stratified by Canadian and US centers.
Results
Patient characteristics
In SPRINT, 1226 patients (93% of 1319 enrolled patients) completed
the final 1-year follow-up visit and were included in this and pre-
vious analyses [8]. Included patients were predominantly men
with a mean age of about 40 years old (Table 1). Two-thirds of
study patients had a closed tibia fracture and one-third had an
open tibia fracture. The convenience sample of 235 patients (118 in
reamed and 117 in unreamed group) included in the cost analysis
was similar to patients not included in the cost analysis, and pa-
Table 1 – SPRINT patient demographics and fracture chara
Economic review
Closed
Reamed Unreamed Rea
N  85 N  82 N
Age, mean (SD) 44.1 (16.9) 40.6 (16.6) 34.5
Sex, n (%)
Male 51 (60.0) 55 (67.1) 28
Female 34 (40.0) 27 (32.9) 5
Smoking history, n (%)*
Non-smoker 57 (67.1) 47 (58.0) 18
Current smoker 20 (23.5) 19 (23.5) 13
Previous smoker 8 (9.4) 15 (18.5) 1
Leg fractured, n (%)
Isolated
Left 42 (49.4) 34 (41.5) 15
Right 41 (48.2) 48 (58.5) 17
Bilateral 2 (2.4) 0 (0) 1
Both open and closed fracture, n (%) 0 (0) 0 (0) 1
Isolated fractures, n (%) 59 (69.4) 61 (74.4) 19
Type of fracture†, n (%)
Open — — 5
Type I 11
Type II 13
Type IIIA 4
Type IIIB
Closed*
Tscherne 0–1 75 (88.2) 78 (95.1)
Tscherne 2–3 10 (11.8) 4 (4.9)
AO classification†, n (%)
A (simple) 47 (55.3) 58 (70.7) 14
B (wedge) 28 (32.9) 19 (23.2) 13
C (complex) 10 (11.8) 5 (6.1) 6
Bone loss in open fractures†, n (%) — —
Yes 11
No 22
SD, standard deviation; SPRINT, study to prospectively evaluate ream
* Some missing data.
† Based on most severe for bilateral fractures.tients allocated to reamed intramedullary nailing were similar to apatients allocated to unreamed intramedullary nailing with re-
spect to key prognostic variables except for a larger proportion of
patients with a grade III open fracture in the reamed compared
with the unreamed group (Table 1).
Patient outcomes
The primary outcome of the SPRINT trial, which was a composite of
re-operations including autodynamization, showed a benefit for
reamed intramedullary nail insertion in patients with closed tibial
shaft fractures largely due to fewer dynamizations, and a potential
advantage for unreamed intramedullary nailing in open tibia frac-
tures (Table 2). The mean utility scores (overall health) during the
first 12 months following intramedullary nailing were similar in the
unreamed group and the reamed groups for both open and closed
tibia fractures (Table 2). Closed tibia fractures in general were asso-
ciated with higher utility scores than open tibia fractures (Table 2).
Cost analysis
Table 3 summarizes health care resource utilization. Table 4 sum-
arizes the unit costs for the hospitalization, clinic follow-up, and
e-operations. Consumed resources during the index hospital stay
stics.
ents SPRINT patients not in economic review
Open Closed Open
Unreamed Reamed Unreamed Reamed Unreamed
N  35 N  331 N  328 N  173 N  159
) 36.8 (15.9) 38.9 (15.7) 39.9 (16.0) 37.7 (16.7) 40.1 (15.4)
) 23 (65.7) 243 (73.4) 248 (75.6) 135 (78.0) 121 (76.1)
) 12 (34.3) 88 (26.6) 80 (24.4) 38 (22.0) 38 (23.9)
) 24 (68.6) 195 (59.3) 180 (54.9) 94 (54.7) 96 (60.4)
) 8 (22.9) 107 (32.5) 123 (37.5) 60 (34.9) 56 (35.2)
3 (8.6) 27 (8.2) 25 (7.6) 18 (10.5) 7 (4.4)
) 15 (42.9) 148 (44.7) 140 (42.7) 74 (42.8) 78 (49.1)
) 18 (51.4) 178 (53.8) 187 (57.0) 92 (53.2) 77 (48.4)
2 (5.7) 5 (1.5) 1 (0.3) 7 (4.0) 4 (2.5)
2 (5.7) 0 (0) 0 (0) 3 (1.7 ) 2 (1.3)
) 23 (65.7) 234 (70.7) 221 (67.4) 106 (61.3) 102 (64.2)
) 13 (37.1) — — 40 (23.1) 49 (30.8)
) 16 (45.7) 73 (42.2) 58 (36.5)
) 5 (14.3) 45 (26.0) 42 (26.4)
) 1 (2.9) 15 (8.7) 10 (6.3)
— — —
268 (81.2) 258 (78.7)
62 (18.8) 70 (21.3)
) 13 (37.1) 198 (59.8) 195 (59.5) 80(46.2) 82 (51.6)
) 12 (34.3) 88 (26.6) 92 (28.0) 58 (33.5) 52 (32.7)
) 10 (28.6) 45 (13.6) 41 (12.5) 35 (20.2) 25 (15.7)
— —
) 13 (37.1) 36 (20.8) 30 (18.9)
) 22 (62.9) 137 (79.2) 129 (81.1)
tramedullary nails in patients with tibial fractures.cteri
pati
med
 33
(11.9
(84.8
(15.2
(56.3
(40.6
(3.1)
(45.5
(51.5
(3.0)
(3.0)
(57.6
(15.2
(33.3
(39.4
(12.1
—
(42.4
(39.4
(18.2
(33.3
(66.7
ed innd for re-operations were recorded at the time of trial conduct,
ed in
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ical chart review. In general, costs associated with open tibia
fractures were higher than costs associated with closed tibia
fractures (Table 5). Costs from the index procedure, from the
index hospital stay, and from fracture-associated medications
were similar in the reamed and unreamed treatment groups.
However, the costs from re-operations were quite different be-
tween groups.
Mean costs from re-operations were similar for reamed pa-
tients with closed tibia fractures, but higher with open tibia
fractures. The cost difference for “Other costs” (Table 5) be-
tween the reamed and the unreamed group with closed frac-
tures was mainly driven by a considerable difference in costs
Table 2 – Outcomes for the entire SPRINT trial, N = 1226.
Re-operations (primary outcome of SPRINT)
Bone graft
Implant exchange
Re-operation due to local infection
Fasciotomy for compartment syndrome (in a procedure separate
from the intramedullary nailing)
Fasciotomy for compartment syndrome (in the same procedure
as the intramedullary nailing)
Removal of locking screws
Dynamization
In operating room
In outpatient clinic
Autodynamization
Failure of construct (broken nail)
Utility scores from the health utilities index, mean (SD)
Prior to injury
2 weeks
3 months
6 months
12 months
SD, standard deviation; SPRINT, study to prospectively evaluate ream
Table 3 – Health care resource utilization, N=235.
Index hospital length of stay (days on an orthopedic ward)
Mean (SD)
Median (IQR)
Index operating room time
Mean (SD) 7
Median (IQR)
Number of orthopedic surgeon visits
Mean (SD)
Median (IQR)
Number of x-rays
Mean (SD)
Median (IQR)
Number of readmissions
Mean (SD)
Total numberIQR, interquartile range; SD, standard deviation.from rehabilitation institutions. Six patients in the reamed
group and two patients in the unreamed group went to rehabil-
itation institutions for a mean of 25 days (range, 2–80 days),
resulting in a total of rehabilitation costs in the reamed group of
$105,888 Canadian dollars and in the unreamed group of $15,600
Canadian dollars. Because of the small number of patients, the
most likely explanation for the difference is chance.
According to the stratified description of resource utilization
by Canadian and US centers (see Table 1 at: doi:10.1016/j.
jval.2010.10.034), we did not find any differences between Cana-
dian and US centers, except for orthopedic surgeon visits with
open fractures for which there was a trend toward more ortho-
pedic surgeon visits in US centers when compared with Cana-
Closed Open
eamed Unreamed Reamed Unreamed
N  416 N  410 N  206 N  194
45 68 60 46
2 2 7 6
6 10 12 12
9 7 19 16
6 1 3 2
1 6 2 1
1 0 0 0
8 16 17 13
2 3 0 1
12 29 9 8
0 0 0 1
.88 (0.19) 0.88 (0.22) 0.90 (0.16) 0.89 (0.18)
.32 (0.25) 0.35 (0.27) 0.33 (0.29) 0.37 (0.26)
.57 (0.29) 0.58 (0.28) 0.53 (0.32) 0.52 (0.29)
.68 (0.29) 0.68 (0.31) 0.61 (0.31) 0.62 (0.30)
.72 (0.30) 0.76 (0.29) 0.68 (0.30) 0.66 (0.31)
tramedually nails in patients with tibial fractures.
Closed Open
ed Unreamed Reamed Unreamed
85 N  82 N  33 N  35
.6) 7.9 (9.2) 10.3 (6.6) 9.8 (8.9)
–8) 5 (4–9) 7 (6–16) 7 (5–10)
1.7) 66.7 (26.6) 85.6 (30.8) 82.3 (40.5)
8–90) 61 (45–85) 83 (60–110) 80 (55–115)
.5) 5.1 (1.4) 7.6 (4.2) 6.4 (3.0)
–6) 5 (4–6) 6 (5–8) 6 (5–7)
.7) 4.3 (1.5) 5.4 (2.9) 4.6 (1.8)
–5) 4 (3–5) 5 (4–7) 5 (3–6)
.4) 0.1 (0.3) 0.4 (0.7) 0.1 (0.4)
8 13 3R
0
0
0
0
0Ream
N 
6.8 (5
5 (4
4.7 (4
65 (4
5.2 (1
5 (5
4.4 (1
4 (4
0.1 (0
10
: $1 U
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reamed and unreamed intra-medullary nailing.
Cost-utility analysis
In closed fractures, we found a mean increased incremental cost
of $51 Canadian dollars (95% confidence interval [CI] $2298–
$2400) for patients treated with a reamed intramedullary nail
compared to an unreamed nail (Table 6). In open fractures, we
found a mean increased incremental cost of $2546 Canadian dol-
lars (95% CI $1773–$6864) for patients treated with a reamed in-
tramedullary nail. The mean incremental effects on QALYs in
reamed compared to unreamed intramedullary nailing were
0.017 (95% CI 0.058–0.017) and 0.002 (95% CI 0.062–0.060) in
closed and open fractures, respectively. Considering only the
point estimates for both cost and QALYs, unreamed intramedul-
lary nailing was more effective and less costly than reamed in-
tramedullary nailing in both closed and open fractures. The anal-
yses of uncertainty based on the bootstrap replications are shown
on the cost-effectiveness planes in Figure 1A for closed and Figure
1B for open fractures. Representing this uncertainty on cost-effec-
Table 4 – Unit costs of hospitalization, clinic visits, and sur
Hospital and clinic costs Costs
Day on orthopedic ward $696 Ecl
Radiographs of the tibia (2 views) $22 Ph
Fracture clinic visit $58 Ecl
S
Emergency room visit
Initial visit $157 Ecl
SFollow-up visit $102
Surgical procedures
Bone graft $2224 Ecl
(
Implant exchange $4520 Ecl
(
Re-operation due to local infection $890 Ecl
(
Fasciotomy for compartment syndrome $1655 Ecl
(
Removal of locking screws/dynamization
In operating room $1065 Ecl
(In outpatient clinic $70
Costs expressed in Canadian dollars. Average exchange rate for 2008
Table 5 – Average costs based on SPRINT data.
Closed
Reamed
N  85
Total cost, mean (range) $8053 ($3023 to $63,894) $800
Cost for index surgery, mean (range) $1649 ($1002 to $4840) $150
Cost for index hospital stay excluding
the index surgery, mean (range)
$4725 ($1392 to $32,712) $549
Cost for fracture-associated
medications, mean (range)
$95 ($4 to $896) $10
Cost for re-operations (range) $136 ($0 to $3153) $34
Other costs, mean (range)* $1448 ($0 to $48,402) $55
Costs expressed in Canadian dollars. Average exchange rate for 2008
SPRINT, study to prospectively evaluate reamed intramedullary nails
* Other costs comprised cost items such as outpatient fracture clin
imaging, bone density scans, venous Doppler, cast applications, cconsultations, and consultations with a plastic surgeon.tiveness acceptability curves (Fig. 2), shows that for all willingness
to pay thresholds, unreamed nailing was more likely to be cost-
effective at all decision-making thresholds for both closed and
open fractures. However, there is considerable fragility of these
results due to small differences in both cost and effectiveness as-
sociated with large standard errors.
To explore the impact of the higher proportion of patients with
grade III open fractures in the reamed group on our results, we
calculated total costs for open fractures stratified by grades I/II or
grades IIIA/B in a post-hoc sensitivity analysis. Themean (range) of
total costs for patients with open fractures grade I/II were $12,806
Canadian dollars ($4441 to $57,060) in the reamed, and $9999 Ca-
nadian dollars ($2959 to $35,509) in the unreamed group, and for
patients with open fractures grade IIIA/B $12,717 Canadian dollars
($5068 to $31,832) in the reamed, and $11,257 Canadian dollars
($6612 to $19,766) in the unreamed group. Even if we assumed
mean total costs of $11,257 Canadian dollars for all unreamed pa-
tients with open fractures we would still find a considerably lower
point estimate for total costs in patientswith unreamed compared
with reamed open fractures.
l procedures.
Data source
T2 Case Costing System, London, Ontario (2007)
n Schedule of Benefits (February 2008)
T2 Case Costing System, London, Ontario (2007) and Physician
ule of Benefits (February 2008)
T2 Case Costing System, London, Ontario (2007) and Physician
ule of Benefits (February 2008)
T2 Case Costing System (2007) and Physician Schedule of Benefits
ary 2008)
T2 Case Costing System (2007) and Physician Schedule of Benefits
ary 2008)
T2 Case Costing System (2007) and Physician Schedule of Benefits
ary 2008)
T2 Case Costing System (2007) and Physician Schedule of Benefits
ary 2008)
T2 Case Costing System (2007) and Physician Schedule of Benefits
ary 2008)
SD  $1.066 Canadian dollars.
Open
reamed Reamed Unreamed
 82 N  33 N  35
92 to $51,036) $12,760 ($4441 to $57,060) $10,215 ($2959 to $35,509)
0 to $2703) $1805 ($1002 to $2780) $1741 ($870 to $2938)
92 to $48,720) $7192 ($2088 to $18,792) $6821 ($1392 to $32,016)
to $598) $282 ($7 to $2242) $245 ($1 to $2264)
to $12,312) $1989 ($0 to $16,874) $485 ($0 to $8000)
9 to $11,202) $1492 ($241 to $28,141) $923 ($161 to $8962)
SD  $1.066 Canadian dollar.
atients with tibial fractures.
its, radiographs, computed tomography scans, magnetic resonance
movals, air cast boots, rehabilitation institutions, emergency roomgica
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costs listed in Table 4 by 20% (Table 2 found at: doi:10.1016/j
.jval.2010.10.034), we found that unreamed dominated reamed in all
but one of these analyses, which is consistent with our primary re-
sult. Whenwe assumed an increase of 20% in the per day cost on an
orthopedic ward, the reamed group had a lower mean cost than the
unreamedgroup ($9008 and $9124Canadiandollars, respectively) for
closed fracture patients.
Because we found a considerable difference in rehabilitation
costs between groups for closed fractures which was most likely
Table 6 – Cost-utility analysis results.
Costs ($) mean
(95% CI)
QALYs mean
(95% CI*)
Increm
($) me
Closed
Reamed $8053 ($6255, $9851) 0.64 (0.61, 0.66) $51 (
Unreamed $802 ($6475, $9528) 0.65 (0.63, 0.68)
Open
Reamed $12,760 ($9138, $16,383) 0.59 (0.55, 0.64) $2546 (
Unreamed $10,215 ($7644, $12,786) 0.59 (0.55, 0.63)
Costs expressed in Canadian dollars. Average exchange rate for 2008
CI, confidence interval; ICER, incremental cost-effectiveness ratio; QA
* 95% CI calculated from bootstrapping for QALYs and incremental e
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Fig. 1 – Incremental cost-effectiveness plane. (A) Closed
fractures. (B) Open fractures. QALY, quality-adjusted life years.due to chance, we conducted a sensitivity analysis excluding re-
habilitation costs from the analysis. This led to a lower mean cost
for the reamed group compared with the unreamed group in closed
fractures (Table 3 foundat: doi:10.1016/j.jval.2010.10.034) underlining
the fragility of our point estimate results.
Discussion
Waiting lists for surgical procedures are long in Canada [17] and
health care costs continue to climb [18]. Therefore, means to pre-
vent re-operations and reduce costs are important. We found
small differences in both cost and effectiveness in favor of un-
reamed intramedullary nailing compared to reamed intramedul-
lary nailing in both closed and open fractures. However, the con-
al costs
5% CI)
Incremental effects
(QALYs) mean
(95% CI*)
ICER
8, $2400) 0.017 (0.058, 0.021) Unreamed dominates reamed
3, $6864) 0.002 (0.062, 0.060) Unreamed dominates reamed
SD  $1.066 Canadian dollar.
quality-adjusted life years.
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and effectiveness are wide, indicating a considerable amount of
uncertainty and precluding firm conclusions regarding relative
benefit and cost. Another interpretation of our results, inwhich for
decision-making purposes probabilities for incremental cost-ef-
fectiveness are directly compared given the available data, could
conclude that unreamed intramedullary nailing dominates
reamed nailing for both closed and open tibial fractures; this ap-
proach, however, ignores the fragility of the results.
Strengths and limitations
The strengths of this study are the large sample size of the SPRINT
trial; its high internal validity through strategies to reduce bias
that include centralized randomization of patients to ensure con-
cealment, and independent, blinded adjudication of outcome
events; and its pragmatic nature: patients enrolled in SPRINTwere
typical of the normal case load, the operative approaches reflect
current care, a wide range of end points was measured (e.g., dif-
ferent types of re-operations, patients’ functional status, and
quality of life), and the multiple participating surgeons and cen-
ters are fairly representative of the United States and Canada [8].
The hypothesis that effects differ in open and closed frac-
tures was specified a priori, reflected in the decision to stratify
randomization according to open and closed fractures [9]. Other
factors supporting the credibility of a subgroup effect are the
large difference in effect size of the primary outcome in this
within-study comparison, the fact that it was statistically sig-
nificant (P 0.01), and that it is biologically plausible since pres-
ervation of the endosteal blood supplymight bemore important
in open than in closed fractures.
We acknowledge the possibility of a short-term bias since our
study was constrained to the trial period of 1 year. However, the
time horizon of one year appears reasonable for this analysis be-
cause re-operations for tibial fractures typically occur within the
first year following surgery, and closed tibia fractures usually heal
at a mean of 3.9 months and open tibial fractures at a mean of 7
months [8]. Given this fact and our results, a follow-up beyond 1
year would have probably yielded little additional information
about resource utilization and quality of life; although it is possible
that a decision analytic model with a lifetime horizon could have
yielded different results, we consider this unlikely.
Although this economic evaluation was planned from the ini-
tiation of the SPRINT trial and the most important data were col-
lected during the trial conduct, part of the resource utilization data
was collected retrospectively through review of medical records
on a non-random sample of less than one-fifth of SPRINT patients.
Resource items such as physiotherapy, occupational therapy, so-
cial workers, and blood testswere not systematically captured and
were therefore omitted in the analysis. Further information
sources such as family physicians were not contacted to comple-
ment information on consumed follow-up resources found in hos-
pital charts. A trend toward more orthopedic surgeon visits in US
centers when compared with Canadian centers was equally pres-
ent for reamed and unreamed intra-medullary nailing and is
therefore unlikely to have biased our results.
In order to optimize the signal-noise ratio, this analysis fo-
cused on relative cost differences between reamed and unreamed
nail groups, and made no attempt to accurately reflect absolute
costs of intramedullary nailing of tibia fractures. Therefore, surgi-
cal procedures classified by the adjudication committee as non-
events (re-operations determined by the circumstances of the in-
jury rather than by the different operative techniques) were not
included in the analysis. Along the same lines, we did not include
any after hours or weekend surcharges and we considered mate-
rial costs of intramedullary nails and locking screws only for re-
operations such as implant exchanges.Finally, the generalizability of the study results is limited to the
extent that peri-operative regimens were standardized in partici-
pating centers [9]. Although SPRINT was a pragmatic trial, these
measures probably increased the internal validity of the trial but
made it less representative of usual clinical practice.
Findings in relation to prior evidence
The SPRINT primary manuscript reported a benefit for reamed
intramedullary nail insertion in patients with closed tibial shaft
fractures, and a potential advantage for unreamed intramedullary
nailing in open tibia fractures [8]. This economic evaluation found
that unreamed intramedullary nailingwasmore effective and less
costly when compared to reamed intramedullary nailing for both
open and closed fractures. Confidence intervals around both cost
and utility estimates were, however, wide, and neither ap-
proached conventional levels of statistical significance. The re-
sults from the primary SPRINT manuscript were largely driven by
fewer dynamizations and autodynamizations [8] in the reamed
group, but these had negligible impact on the cost-effectiveness
because there is little or no cost associated with autodynamiza-
tions, and the differences in autodynamization did not appear to
affect the results of the utility measures.
There has been limited economic research in this area. The
results of a previously published economic evaluation of reamed
versus unreamed intramedullary nailing in 51 patients with open
tibia fractures reported fewer costs with reamed intramedullary
nailing due to fewer secondary procedures while healing rates
remained similar in the two groups [6]. This study is limited by the
biases that accompany any observational study and by the small
sample size. Similarly, Busse et al. [7] reported that from an eco-
nomic standpoint, the reamed intramedullary nail is the treat-
ment of choice for low energy tibia fractures. To develop their
decision tree, Busse et al. [7] used data from small randomized
linical trials with methodological limitations. The prospective,
andomized SPRINT trial with concealed 24-hour allocation of pa-
ients provides higher internal validity, and its results in favor of
he unreamed technique for open tibia fractures may be a conser-
ative estimate for a potential benefit since participating surgeons
ad superior skills in reamed nailing.
Conclusions
Our economic analysis from a governmental perspective found no
convincing evidence of differences between reamed and un-
reamed nailing in either cost and effectiveness with wide confi-
dence intervals. The uncertainty regarding the relative cost and
utility of the procedures suggests that results based on point
estimates, in which unreamed intramedullary nailing domi-
nated reamed nailing for both closed and open tibial shaft frac-
tures, should be viewed with great caution.
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